318 related articles for article (PubMed ID: 38303967)
1. Accelerating the understanding of
Thakur R; Shishodia SK; Sharma A; Chauhan A; Kaur S; Shankar J
Curr Res Microb Sci; 2024; 6():100220. PubMed ID: 38303967
[No Abstract] [Full Text] [Related]
2. Proteomic analysis revealed ROS-mediated growth inhibition of Aspergillus terreus by shikonin.
Shishodia SK; Shankar J
J Proteomics; 2020 Jul; 224():103849. PubMed ID: 32485396
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing.
Kathuria S; Sharma C; Singh PK; Agarwal P; Agarwal K; Hagen F; Meis JF; Chowdhary A
PLoS One; 2015; 10(3):e0118997. PubMed ID: 25781896
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience.
Lass-Flörl C; Griff K; Mayr A; Petzer A; Gastl G; Bonatti H; Freund M; Kropshofer G; Dierich MP; Nachbaur D
Br J Haematol; 2005 Oct; 131(2):201-7. PubMed ID: 16197450
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus terreus Species Complex.
Lass-Flörl C; Dietl AM; Kontoyiannis DP; Brock M
Clin Microbiol Rev; 2021 Dec; 34(4):e0031120. PubMed ID: 34190571
[TBL] [Abstract][Full Text] [Related]
6. Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
Lackner M; Birch M; Naschberger V; Grässle D; Beckmann N; Warn P; Gould J; Law D; Lass-Flörl C; Binder U
J Antimicrob Chemother; 2018 Nov; 73(11):3068-3073. PubMed ID: 30351438
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Aspergillus terreus at a university hospital.
Baddley JW; Pappas PG; Smith AC; Moser SA
J Clin Microbiol; 2003 Dec; 41(12):5525-9. PubMed ID: 14662934
[TBL] [Abstract][Full Text] [Related]
8. Luliconazole, an alternative antifungal agent against Aspergillus terreus.
Zargaran M; Taghipour S; Kiasat N; Aboualigalehdari E; Rezaei-Matehkolaei A; Zarei Mahmoudabadi A; Shamsizadeh F
J Mycol Med; 2017 Sep; 27(3):351-356. PubMed ID: 28483449
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive interferon-γ immunotherapy in a pediatric case of Aspergillus terreus infection.
Assendorp EL; Gresnigt MS; Sprenkeler EGG; Meis JF; Dors N; van der Linden JWM; Henriet SSV
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1915-1922. PubMed ID: 30027379
[TBL] [Abstract][Full Text] [Related]
10. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
11. Persistence within dendritic cells marks an antifungal evasion and dissemination strategy of Aspergillus terreus.
Hsieh SH; Kurzai O; Brock M
Sci Rep; 2017 Sep; 7(1):10590. PubMed ID: 28878289
[TBL] [Abstract][Full Text] [Related]
12. Antifungal resistance in Aspergillus terreus: A current scenario.
Vahedi Shahandashti R; Lass-Flörl C
Fungal Genet Biol; 2019 Oct; 131():103247. PubMed ID: 31247322
[TBL] [Abstract][Full Text] [Related]
13. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study.
Rüping MJ; Gerlach S; Fischer G; Lass-Flörl C; Hellmich M; Vehreschild JJ; Cornely OA
J Hosp Infect; 2011 Jul; 78(3):226-30. PubMed ID: 21440331
[TBL] [Abstract][Full Text] [Related]
14. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
[TBL] [Abstract][Full Text] [Related]
15. Proteome Profile of Aspergillus terreus Conidia at Germinating Stage: Identification of Probable Virulent Factors and Enzymes from Mycotoxin Pathways.
Thakur R; Shankar J
Mycopathologia; 2017 Oct; 182(9-10):771-784. PubMed ID: 28647921
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Infections Due to
Lass-Flörl C
J Fungi (Basel); 2018 Jul; 4(3):. PubMed ID: 29987241
[TBL] [Abstract][Full Text] [Related]
17.
Vahedi-Shahandashti R; Dietl AM; Binder U; Nagl M; Würzner R; Lass-Flörl C
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0227421. PubMed ID: 35254091
[TBL] [Abstract][Full Text] [Related]
18. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Aspergillus terreus infections: a clinical problem not yet resolved.
Pastor FJ; Guarro J
Int J Antimicrob Agents; 2014 Oct; 44(4):281-9. PubMed ID: 25190543
[TBL] [Abstract][Full Text] [Related]
20. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR
Clin Microbiol Infect; 2003 Dec; 9(12):1238-41. PubMed ID: 14686991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
